Rani Therapeutics Holdings (RANI) Depreciation and Depletion (2021 - 2026)
Rani Therapeutics Holdings' (RANI) quarterly Depreciation and Depletion came in at $200000.0 in Q1 2026, down 33.33% year-on-year from $300000.0 in Q1 2025, and down 33.33% quarter-over-quarter from $300000.0 in Q1 2025.
Rani Therapeutics Holdings (RANI) Depreciation and Depletion (2021 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Depreciation and Depletion history runs 4 years deep, the most recent figure standing at $200000.0 for Q1 2026.
- On a quarterly basis, Depreciation and Depletion fell 33.33% year-over-year to $200000.0 in Q1 2026; TTM through Mar 2026 was $767000.0, a 11.32% increase from a year earlier, with the FY2025 full-year figure at $900000.0, down 10.0% from the prior year.
- Depreciation and Depletion fell to $200000.0 in Q1 2026 per RANI's latest filing, from $300000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $300000.0 in Q1 2025 and bottomed at $111000.0 in Q1 2022.
- The 3-year median for Depreciation and Depletion is $133500.0 (2022), against an average of $166666.7.
- Across the five-year window, Depreciation and Depletion grew 17.5% in 2022 and sank 33.33% in 2026, its largest moves.
- Year by year, Depreciation and Depletion stood at $126000.0 in 2022, then soared by 138.1% to $300000.0 in 2025, then tumbled by 33.33% to $200000.0 in 2026.
- Per Business Quant, the three latest RANI Depreciation and Depletion figures stand at $200000.0 (Q1 2026), $300000.0 (Q1 2025), and $126000.0 (Q4 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2022 | 126,000.00 |
| Dec 31, 2022 | 126,000.00 |
| Sep 30, 2022 | 141,000.00 |
| Sep 30, 2022 | 141,000.00 |
| Jun 30, 2022 | 122,000.00 |
| Jun 30, 2022 | 122,000.00 |
| Mar 31, 2022 | 111,000.00 |
| Mar 31, 2022 | 111,000.00 |
| Dec 31, 2021 | 116,000.00 |
| Dec 31, 2021 | 116,000.00 |
| Sep 30, 2021 | 120,000.00 |
| Sep 30, 2021 | 120,000.00 |
| Jun 30, 2021 | 128,000.00 |
| Jun 30, 2021 | 128,000.00 |
| Mar 31, 2021 | 136,000.00 |
| Mar 31, 2021 | 136,000.00 |